Skip to main content
FinSpry Logo
FinSpry
RGNX logo
RGNX
(NASDAQ)
REGENXBIO Inc.
$10.72-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

REGENXBIO (RGNX) Stock Price & Financial Analysis

REGENXBIO Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.31 - $11.39
52-Week High$16.19
52-Week Low$5.46
Open$11.05
Volume1.39M
Average Volume (3M)2.16M
Market Cap562.03M
Shares Outstanding52.43M
Price to Sales (P/S)6.40
Price to Book (P/B)26.66
EV/EBITDA-2.69
Revenue (TTM)87.82M
Net Income (TTM)-290.01M
Free Cash Flow (TTM)-236.40M
EPS (TTM)$-5.59
Profit Margin-330.23%
Operating Margin-292.28%
Return on Equity (ROE)-1375.64%
Debt to Equity3.37
50-Day MA$9.88
200-Day MA$10.53
52-Week Change35.70%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About REGENXBIO

What is the current stock price for RGNX?

As of the latest trading session, RGNX stock trades at $10.72. The 52-week range is $5.46–$16.19, with a day range of $10.31–$11.39.

What is the P/E ratio for RGNX?

The P/E ratio (Price-to-Earnings) for RGNX is shown in the Key Statistics section. This valuation metric helps compare REGENXBIO Inc. to industry peers.

Does RGNX pay dividends?

REGENXBIO does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGNX?

Based on 9 analysts, the consensus for RGNX is Buy.

What is the market cap of RGNX?

REGENXBIO's market capitalization is $562.0M, classifying it as a small-cap company. REGENXBIO operates in the Healthcare sector within the Biotechnology industry.